Frown Lines
5
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Treatment With Cryotouch Iv
Research Leaders
5 sponsors active, led by Pacira Pharmaceuticals, Inc
Related Conditions
Often studied with 4 related conditions
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (5)
Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
A Prospective Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the Cryo-Touch IV Device
Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device
BOTOX® in the Treatment of Upper Facial Lines in Japan
Research Network
Common Treatments
- Treatment With Cryotouch Iv1
- Botulinum Toxin A Bontadp1
- Botulinum Toxin A Botox Cosmetics1
- Botulinum Toxin Type A 44u1
- Treatment With Cryotouch Iii Device1
Active Sponsors
- Pacira Pharmaceuticals, Inc2
- Hugel1
- Revance Therapeutics, Inc.1
- Allergan1
- Croma-Pharma GmbH1
Top Investigators
77 Plastic Surgery
77 Plastic Surgery
Related Conditions
- Glabellar Frown Lines2
- Upper Facial Rhytides1
- Crows Feet Lines1
- Glabellar Lines1